Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EADO 2022 | Real-life data with sonidegib for locally advanced basal cell carcinoma

Iris Zalaudek • 26 Apr 2022
EADO 2022
Melanoma Skin Cancer Sonidegib

Iris Zalaudek, MD, PhD, Dermatology Clinic, University of Trieste, Maggiore Hospital, Trieste, Italy, talks on real-life data with sonidegib for locally advanced basal cell carcinoma including the common side-effects observed. Overall, the findings were promising, indicating sonidegib is well tolerated amongst this patient population. This interview took place at the EADO 2022 congress.

More from Iris Zalaudek

Refining follow-up strategies to address overdiagnosis in early-stage melanoma
3:07
Refining follow-up strategies to address overdiagnosis in early-stage melanoma
Iris Zalaudek • 3 Apr 2025
Rethinking melanoma follow-up: patient education over routine imaging
2:09
Rethinking melanoma follow-up: patient education over routine imaging
Iris Zalaudek • 3 Apr 2025
The evolving role of AI and imaging in melanoma diagnosis and staging
0:57
The evolving role of AI and imaging in melanoma diagnosis and staging
Iris Zalaudek • 3 Apr 2025
New EADO guidelines
1:04
New EADO guidelines
Iris Zalaudek • 26 Apr 2022

Related Videos

BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
1:45
BRAF/MEK inhibition prior to immunotherapy in melanoma: insights from the COWBOY trial
Kalijn Bol • 31 May 2026
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
1:08
COWBOY trial: optimal sequencing of BRAF/MEK inhibition and immunotherapy in BRAF-mutated melanoma
Kalijn Bol • 31 May 2026
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
1:02
Could induction BRAF/MEK inhibition be useful for some melanoma patients with metastases?
Kalijn Bol • 31 May 2026
The future of personalized and off-the-shelf mRNA vaccines in melanoma
1:02
The future of personalized and off-the-shelf mRNA vaccines in melanoma
James Smithy • 31 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals